Death due to cardiovascular disease is on the rise in India, causing more than one quarter of all deaths in the country in 2015 and affecting rural populations and young adults the most, suggests a new study.
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system. The study was published by Nature Communications.
Experts are drawing on lessons learned from the early days of the HIV epidemic to address the current opioid epidemic. As a result of widespread opioid abuse, new epidemics of hepatitis C virus (HCV) and HIV infection have arisen and hospitalizations for related infections have increased. An expert panel convened by the National Academies of Sciences, Engineering, and Medicine (NASEM) recommends five crucial steps for clinicians treating patients affected by opioid addiction and these intersecting infections.
A new scientific study finds 93 people live in remote areas with venomous snakes and, if bitten, face a greater likelihood of dying than those in urban settings because of poor access to anti-venom medications.
Countries have traditionally been divided into two broad categories according to their capacity to innovate. Now, researchers reporting in PLOS Neglected Tropical Diseases say these categories are overly simplistic and leave out the key roles that a group of Innovative Developing Countries (IDCs) play in the public health arena.
Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).
Research by a team led by Dr. Elizabeth Fullam has revealed new findings about an enzyme found in Mycobacterium tuberculosis (Mtb), the bacterium that causes TB.
Researchers have shed new light on the psychiatric and neurological problems that Ebola survivors can suffer from, and call for more specialist support for the most severely affected patients.
The bacteria that cause the devastating disease tuberculosis have the ability to escape destruction and grow after they are engulfed by lung macrophages, the immune cells that are supposed to destroy pathogens. Now researchers at the University of Alabama at Birmingham have described key biochemical steps between the bacteria Mycobacterium tuberculosis and the macrophage responsible for that ability.
Researchers at the Morgridge Institute for Research shed light on the complex life cycle of Schistosoma, a parasite responsible for sickening hundreds of millions of people in the developing world.